This study suggests that avoidance of major polypharmacy, use of nonpharmacological measures to improve lifestyle habits and decreasing the exposure of physicians to drug promotional material may reduce the risk of PIM use in older primary care outpatients. The only modifiable protective factors for PPOs were working environment of the patients chosen GPs and more frequent ambulatory visits to specialists.
In intubated newborns, measurements of presepsin obtained from tracheal aspirate suggested that it can be used as a complementary marker in diagnosing early onset neonatal pneumonia.
Results: Results revealed five independent predictors of frequent exacerbations: age, length of hospital stay, FEV1/FVC ratio, CRP level above 10 mg/L, and respiratory comorbidities.
Conclusion:COPD patients should be more carefully assessed in terms of age, length of hospital stay, FEV1/FVC ratio, CRP level, and respiratory comorbidities. Patients under 65 years of age with respiratory comorbidities, longer hospital stay, lower FEV1/FVC ratio and CRP of <10 mg/L are more prone to experiencing a minimum of one additional hospitalization in the following year. Patients could spend less time in the hospital environment and increase their quality of life by adjusting these risk factors for hospitalization due to COPD.
Инфекције уринарног тракта су чест узрок прописивања антибиотске терапије. Познавање врсте патогена и њихове резистенције на антибиотике може помоћи при одабиру адекватне терапије. У овој студији су испитивани преваленца и степен резистенције узрочника инфекција уринарног тракта хоспитализованих пацијената. Спроведена је студија пресека у болничким условима. Узето је укупно 662 узорака урина пацијената са инфекцијом уринарног тракта који су анализирани стандардном процедуром. Коришћена је диск дифузиона метода на Милер-Хинтон агару, а процена антимикробне осетљивости је извршена према Clinical and Laboratory Standards Institute смерницама. Најчешћи изоловани патогени су били Klebsiella spp. (219 изолата, тј. 33,1%), затим Proteus mirabilis (107 изолата, тј. 16,2%), Enterobacter (86 изолата, тј. 13%), Escherichia
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.